R&D investment and total factor productivity in China’s pharmaceutical industry: The moderating effect of the centralized procurement policy

R&D investment and total factor productivity in China’s pharmaceutical industry: The moderating effect of the centralized procurement policy

Saved in:

Bibliographic Details
Main Authors:	Xiujuan Li, Jiachun Xu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12088054/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Will centralized drug procurement policy improve enterprises’ total factor productivity?
by: Xin Li, et al.
Published: (2025-07-01)

Alternative strategies for investing in corporate R&D (on the example of the global pharmaceutical industry)
by: О. A. Yeremchenko
Published: (2018-12-01)

Pharmaceutical expenditure changes under the volume-based procurement policy: Effects and influencing factors
by: Ying Yang, et al.
Published: (2025-01-01)

Examining how fiscal policies influence innovation in TCM enterprises: the role of R&D investment and executives with pharmaceutical backgrounds
by: Dan Guo, et al.
Published: (2025-02-01)

Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023
by: Fanyu Lin, et al.
Published: (2025-07-01)

EXPLORING THE MODERATION ROLE OF TENDERPRENEURSHIP ON PROCUREMENT PLANNING AND VALUE FOR MONEY IN TANZANIA’S PUBLIC PROCUREMENT
by: Yohana Arsen RUTABA
Published: (2024-01-01)

Environmental regulation, R&D subsidies, and industrial green total factor productivity
by: Bu Wei, et al.
Published: (2024-12-01)

Green Supply Chain Integration and Sustainable Performance in Pharmaceutical Industry of China: A Moderated Mediation Model
by: Huahui Li, et al.
Published: (2025-05-01)

IMPLEMENTATION MECHANISMS OF INNOVATIVE STRATEGIES IN PHARMACEUTICAL INDUSTRY AND KEY INVESTMENT PROJECTS
by: Marko Jovanovich
Published: (2016-08-01)

Research and development investment of Chinese chemical pharmaceutical companies under the national pooled procurement: a retrospective panel data analysis, 2013–2022
by: Yuanli Liu, et al.
Published: (2024-11-01)

Can the accepting foreign clinical data policy improve innovation investment of pharmaceutical firms? Empirical evidence from China
by: Mengjuan Jiang, et al.
Published: (2025-07-01)

TRANSFORMATION OF PUBLIC PROCUREMENT OF INDUSTRIAL PRODUCTS TAKING INTO ACCOUNT THE ENVIRONMENTAL FACTOR
by: A. E. Gukasova, et al.
Published: (2020-09-01)

Public procurement of light industry products under martial law conditions
by: Zavgorodnia M. Yu., et al.
Published: (2024-10-01)

Knowledge, attitudes, and practices of outpatients regarding National centralized drug procurement policy: a multicenter cross-sectional study in North China
by: Yijie Ma, et al.
Published: (2025-07-01)

R&D Deduction Policy and Corporate Industry Chain Linkage: Evidence From China
by: Tingting Wu, et al.
Published: (2025-08-01)

Policy Evolution of Government Procurement of Public Services in China: A Text-Mining Perspective
by: Dongdan Zhu, et al.
Published: (2023-01-01)

Transformative Procurement Trends: Integrating Industry 4.0 Technologies for Enhanced Procurement Processes
by: Areej Althabatah, et al.
Published: (2023-09-01)

Analysis of Corruption Prevention Forms and Policies in Goods and Services Procurement: E-Procurement as a Solution
by: Deta Helisa Nova, et al.
Published: (2024-11-01)

Research on green total factor productivity of China’s mining industry
by: Yu-Yang Li, et al.
Published: (2025-06-01)

Public Procurement Policies to Foster Innovation Development
by: Mohammad Reza Attarpour, et al.
Published: (2024-04-01)

Healthcare professionals’ knowledge, attitudes, and practices regarding China’s National Centralized Drug Procurement policy: a cross-sectional study in Shaanxi Province
by: Qian Shen, et al.
Published: (2025-08-01)

Public Innovation Policy in the Pharmaceutical Industry: the Cases of the EU and USA
by: Z. A. Mamedyarov
Published: (2017-04-01)

E-Procurement and Procurement Performance of Central Government Procuring and Disposing Entities in Uganda: A Case Study of Kabale Regional Referral Hospital.
by: Kekitinisa, Privas
Published: (2024)

Comparative study on government subsidy models for competitive drug supply chains under centralized procurement policy
by: Yan Wen, et al.
Published: (2025-03-01)

The Influence of Environmental Policy on Green Total Factor Productivity in the Chinese Construction Industry
by: Weizhong Zhou, et al.
Published: (2025-07-01)

Digital inclusion finance, government subsidies and R&D investment—empirical evidence based on listed Chinese pharmaceutical firms
by: XYv Zhao, et al.
Published: (2025-04-01)

The Managerial and Government Ownership Effect on Dividend Policy: The Moderating Role of Investment Opportunities
by: Abdul Fatah Ismail, et al.
Published: (2024-10-01)

Implementation of innovation policy based on the mechanism of public procurement
by: E. P. Malevich, et al.
Published: (2025-03-01)

GREEN PUBLIC PROCUREMENT AS A CIRCULAR ECONOMY POLICY
by: Dumitru Florin FRONE, et al.
Published: (2023-01-01)

An integrated approach of sustainable procurement and procurement postponement for the multi-product, assemble-to-order (ATO) production system
by: Krishnendu Mukherjee
Published: (2016-06-01)

Narcissistic Chief Executive Officers and Their Effects on R&D Investment and Firm Performance: The Moderating Role of Managerial Discretion
by: Qingzhu Gao, et al.
Published: (2024-11-01)

Investment analysis and risk management in pharmaceutical companies
by: Mustafa Özyeşil, et al.
Published: (2025-05-01)

Electrodynamic Technologies in the Eco-industry of Food and Pharmaceutical Production
by: Burdo O.G., et al.
Published: (2023-05-01)

Sustainable procurement practices in the Brazilian chemical industry context
by: Roberta Souza, et al.
Published: (2020-07-01)

Spatial Heterogeneity of Plant‐Level CCUS Investment Decisions in China's Cement Industry Under Various Policy Incentives
by: Yifan Mao, et al.
Published: (2025-03-01)

MODERN PROBLEMS OF CARRYING OUT POLICY OF IMPORT SUBSTITUTION IN PHARMACEUTICAL INDUSTRY IN RUSSIA
by: O. Mishina, et al.
Published: (2016-12-01)

The Impact of Policy Thematic Differences on Industrial Development: An Empirical Study Based on China’s Electric Vehicle Industry Policies at the Central and Local Levels
by: Zizheng Liu, et al.
Published: (2024-11-01)

Affordability of Original and Generic Antihypertensive Drugs Under the National Centralized Drug Procurement Policy and Basic Medical Insurance System: A Cross-Sectional Survey in Xi’an, China
by: Yamin Zou, et al.
Published: (2024-01-01)

Intelligent manufacturing policy, ESG performance, and total factor productivity: Evidence from China.
by: Haiyue Liu, et al.
Published: (2025-01-01)

How do inside directors affect corporate R&D investment? The moderating role of CEO equity incentives.
by: Jianqing Zhou, et al.
Published: (2025-01-01)